Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes

NCT03782610 is registered in ClinicalTrials.gov with Nationwide Children's Hospital as lead sponsor.

NCT NCT03782610
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03782610 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes
Lead sponsor
Nationwide Children's Hospital
Phase
Observational
Overall status
Active, not recruiting
Start date
April 1, 2019
Completion date
September 30, 2026
Enrollment
526 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

bronchopulmonary dysplasia, neurodevelopmental abnormality, patent ductus arteriosus, preterm infant